Navigation Links
NCPA Comments on FTC Action Against CVS Caremark, Vows to Continue PBM Transparency Efforts
Date:1/12/2012

ALEXANDRIA, Va., Jan. 12, 2012 /PRNewswire-USNewswire/ -- The Federal Trade Commission (FTC) announced today that CVS Caremark agreed to pay $5 million to settle allegations that the company overcharged seniors and taxpayers in the Medicare prescription drug program and that the FTC has concluded its investigation into charges alleging that CVS Caremark engaged in anti-consumer, anticompetitive business practices following the 2007 merger of mega-chain CVS with pharmacy benefit manager (PBM) Caremark. The FTC inquiry was launched at the urging of the National Community Pharmacists Association (NCPA) and others.

NCPA CEO B. Douglas Hoey, RPh, MBA issued the following statement in response:

"We appreciate the FTC reviewing the evidence and concerns brought by NCPA, patients, members of Congress and others regarding anti-consumer, anticompetitive behavior by CVS Caremark. The investigation resulted in a multi-million dollar settlement of claims that CVS Caremark overcharged seniors and taxpayers and misled beneficiaries in its marketing of prescription drug plans on Medicare's Plan Finder Website. The settlement should also serve as a warning to any Medicare drug plan sponsors that have potentially misled seniors in their promotion of so-called 'preferred pharmacy' plans.

"At the same time, it is regrettable that the FTC's actions fell short of more robust protections for consumers and pharmacy competition, which are warranted in our view. NCPA provided to the agency what we believe to be compelling evidence, including one-sided contract terms with pharmacy small business owners, patient privacy concerns and a lack of transparency. Now more than ever, NCPA urges Congress and state legislatures to enact legislation, such as S. 1058/H.R. 1971, that provides transparency and promotes pharmacy competition and consumer protections to address these types of questionable practices.

"On behalf of its community pharmacist members and their patients, NCPA opposed the merger of CVS and Caremark from day one. The union of these companies further compounds the inherent, 'the fox is guarding the henhouse' problem with today's prescription drug benefit system. The major PBMs stand virtually alone in the health care sector as self-dealing entities allowed to both provide a health service and manage the reimbursement and other terms of that service for their competitors. Mergers such as CVS Caremark and the pending Express Scripts-Medco arrangement simply pour gasoline on that fire and increase prescription drug costs.

"We appreciate the patients and pharmacists who provided evidence about CVS Caremark's conduct and questionable practices by PBMs. Our efforts concerning CVS Caremark are all part of the ongoing, years-long initiative at NCPA to increase transparency in prescription drug benefit administration and to align the interests of payers, patients, and pharmacists. Those efforts will continue going forward."

The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 23,000 independent community pharmacies. Together they represent a $93 billion health care marketplace, dispense nearly 40% of all retail prescriptions, and employ more than 315,000 people, including 62,400 pharmacists.  Independent community pharmacists are readily accessible medication experts who can help lower health care spending. They are committed to maximizing the appropriate use of lower-cost generic drugs and reducing the estimated $290 billion that is wasted annually by improper medication use. To learn more go to www.ncpanet.org or read NCPA's blog, The Dose, at http://ncpanet.wordpress.com.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
2. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
3. Arpida Provides Further Comments on the Pivotal Phase III Trials
4. SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
5. Arpida Comments on FDAs Anti-infective Drugs Advisory Committee Outcome
6. ACRO Comments on NEJM Article on Globalization of Clinical Research
7. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
8. Endologix Comments on Alleged Patent Infringement
9. AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma
10. Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax
11. Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):